Drug Profile
Epoetin alfa biosimilar - Claris Lifesciences
Alternative Names: Epotin; Recombinant human erythropoietin - Claris LifesciencesLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Claris Lifesciences
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia; Chemotherapy-induced anaemia
Most Recent Events
- 05 Dec 2011 Launched prior to December 2011 for Anaemia (in premature infants) in India (IV)
- 05 Dec 2011 Launched prior to December 2011 for Anaemia in India (IV)
- 05 Dec 2011 Launched prior to December 2011 for Chemotherapy-induced anaemia in India (IV)